Buchert Ralph, Berding Georg, Wilke Florian, Martin Brigitte, von Borczyskowski Daniel, Mester Janos, Brenner Winfried, Clausen Malte
Department of Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany.
Eur J Nucl Med Mol Imaging. 2006 Sep;33(9):1073-83. doi: 10.1007/s00259-006-0067-9. Epub 2006 Apr 14.
Visual reading of [(123)I]IBZM SPECT scans depends on the experience of the interpreter. Therefore, semi-quantification of striatal IBZM uptake is commonly considered mandatory. However, semi-quantification is time consuming and prone to error, particularly if the volumes of interest (VOIs) are positioned manually. Therefore, the present paper proposes a new software tool ("IBZM tool") for fully automated and standardised processing, evaluation and documentation of [(123)I]IBZM SPECT scans.
The IBZM tool is an easy-to-use SPM toolbox. It includes automated procedures for realignment and summation of multiple frames (motion correction), stereotactic normalisation, scaling, VOI analysis of striatum-to-reference ratio R, classification of R and standardised display. In order to evaluate the tool, which was developed at the University of Hamburg, the tool was transferred to the University of Hannover. There it was applied to 27 well-documented subjects: eight patients with multi-system atrophy (MSA), 12 patients with Parkinson's disease (PD) and seven controls. The IBZM tool was compared with manual VOI analysis.
The sensitivity and specificity of the IBZM tool for the differentiation of the MSA subjects from the controls were 100% and 86%, respectively. The IBZM tool provided improved statistical power compared with manual VOI analysis.
The IBZM tool is an expert system for the detection of reduced striatal D(2) availability on [(123)I]IBZM SPECT scans. The standardised documentation supports visual and semi-quantitative evaluation, and it is useful for presenting the findings to the referring physician. The IBZM tool has the potential for widespread use, since it appears to be fairly independent of the performance characteristics of the particular SPECT system used. The tool is available free of charge.
对[(123)I]碘苄胍单光子发射计算机断层扫描(SPECT)图像的视觉解读依赖于解读人员的经验。因此,纹状体碘苄胍摄取的半定量分析通常被认为是必要的。然而,半定量分析既耗时又容易出错,尤其是在手动设置感兴趣区(VOI)时。因此,本文提出了一种新的软件工具(“碘苄胍工具”),用于对[(123)I]碘苄胍SPECT扫描进行全自动、标准化的处理、评估和记录。
碘苄胍工具是一个易于使用的统计参数映射(SPM)工具箱。它包括多帧图像的自动重排和叠加(运动校正)、立体定向归一化、缩放、纹状体与参考区域比值R的感兴趣区分析、R值分类以及标准化显示等自动化程序。为了评估这个由汉堡大学开发的工具,该工具被转移到汉诺威大学。在那里,它被应用于27例有详细记录的受试者:8例多系统萎缩(MSA)患者、12例帕金森病(PD)患者和7例对照者。将碘苄胍工具与手动感兴趣区分析进行比较。
碘苄胍工具区分MSA受试者与对照者的敏感性和特异性分别为100%和86%。与手动感兴趣区分析相比,碘苄胍工具具有更高的统计效能。
碘苄胍工具是一种用于检测[(123)I]碘苄胍SPECT扫描中纹状体D2受体可用性降低的专家系统。标准化记录有助于视觉和半定量评估,并且有助于向转诊医生展示检查结果。碘苄胍工具似乎相当独立于所使用的特定SPECT系统的性能特征,因此有广泛应用的潜力。该工具可免费获取。